Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide.

1993108 citationsJournal Articlebronze Open Access

Authors

Jamal Belkhadir · Centre Hospitalier Ibn Sina

H. El Ghomari · Centre Hospitalier Ibn Sina

Nikolaj Klöcker · Centre Hospitalier Ibn Sina

A Mikou · Centre Hospitalier Ibn Sina

M Nasciri · Centre Hospitalier Ibn Sina

Mayada S. Sabri · Centre Hospitalier Ibn Sina

Abstract

Glibenclamide is effective and safe for patients with non-insulin dependent diabetes who fast during Ramadan. The easiest regimen is to take the normal morning dose (together with any midday dose) at sunset and any evening dose before dawn.

Topics & Keywords

Dietary Effects on Health Diabetes Management and Education

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMJ

Volume 307, Issue 6899, pp. 292-295

DOI: 10.1136/bmj.307.6899.292

Field-Weighted Citation Impact: 1.10